Description
dTpNHpp, a nucleotide analog employed in biomedical research, represents an intriguing prospect as an anti-cancer agent. As a potent and selective inhibitor of polo-like kinases (Plks), preclinical studies reveal its potential to bring about cell cycle arrest and stifle tumor growth. In fact, investigations into cancer therapy have even explored its viability in targeted drug delivery systems